PILOT RANDOMIZED TRIAL of a CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM for PATIENTS WITH MOOD DISORDERS.
PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS.
Filed under: Depression Treatment
Depress Anxiety. 2012 Oct 17;
Kilbourne AM, Li D, Lai Z, Waxmonsky J, Ketter T
OBJECTIVES: Chronic care models improved outcomes… Continue reading
Addiction Rehab: Egocentric Social Network Analysis of Pathological Gambling.
Egocentric Social Network Analysis of Pathological Gambling.
Filed under: Addiction Rehab
Addiction. 2012 Oct 16;
Meisel MK, Clifton AD, Mackillop J, Miller JD, Campbell WK, Goodie AS
AIMS.: To apply social network analysis (SNA) to investigate whether frequency and… Continue reading
Anthony J. Rothschild, MD – Psychotic Depression
Anthony J. Rothschild, MD – Psychotic Depression – Dr. Rothschild talks about what got him interested in psychotic depression and how difficult and under-diagnosed it is today.
One in five Indians needs mental health counselling, reveals… Continue reading
The Association Between Problematic Internet Use and Depression, Suicidal Ideation and Bipolar Disorder Symptoms in Korean Adolescents.
The association between problematic internet use and depression, suicidal ideation and bipolar disorder symptoms in Korean adolescents.
Filed under: Addiction Rehab
Aust N Z J Psychiatry. 2012 Oct 9;
Park S, Hong KE, Park EJ, Ha KS, Yoo HJ… Continue reading
Beyond Muscular Effects: Depression of Spinal Recurrent Inhibition After Botulinum Neurotoxin A.
Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A.
Filed under: Depression Treatment
J Physiol. 2012 Oct 8;
Marchand-Pauvert V, Aymard C, Giboin LS, Dominici F, Rossi A, Mazzocchio R
The natural target of the botulinum… Continue reading
Eating Disorders: Development and Validation of the Self-Management Profile for Type 2 Diabetes (SMP-T2D).
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D).
Filed under: Eating Disorders
Health Qual Life Outcomes. 2012 Oct 5; 10(1): 125
Peyrot M, Bushnell DM, Best JH, Martin ML, Cameron A, Patrick DL
ABSTRACT: BACKGROUND: This study evaluated the measurement properties of a newly developed instrument — the Self-Management Profile for Type 2 Diabetes (SMP-T2D). METHODS: The 18-item SMP-T2D assesses 12 constructs: level and perceived ease of performance in five self-care domains (blood glucose monitoring, medication-taking, healthy eating, being physically active, and coping), and two global constructs (ease of weight management, confidence with ability to manage diabetes). Validation analyses were based on two studies involved 240 patients with T2D, Study 1 (Clinicaltrials.gov #NCT00637273) with SMP-T2D administration supplemented by SMP-T2D retest one week later, and Study 2 (Clinical trials.gov #NCT00877890) with SMP-T2D administration supplemented by 24-week SMP-T2D follow-up after medication change. Validation included clinical indicators and measures of patient reported quality of life, psychological well-being and treatment outcomes. RESULTS: All multi-item SMP-T2D measures showed acceptable internal consistency (alphas = 0.71 to 0.87); ten measures had test-retest reliability >0.75. Correlations… Continue reading
Depression Treatment: Work Reintegration for Veterans With Mental Disorders: A Systematic Literature Reviewto Inform Research.
Work Reintegration for Veterans With Mental Disorders: A Systematic Literature Reviewto Inform Research.
Filed under: Depression Treatment
Phys Ther. 2012 Oct 4;
Vantil L, Fikretoglu D, Pranger T, Patten S, Wang J, Wong M, Zamorski M, Loisel P, Corbiére… Continue reading
Nurses’ Recognition of the Mental State of Cancer Patients and Their Own Stress Management – a Study of Japanese Cancer-Care Nurses.
Nurses’ recognition of the mental state of cancer patients and their own stress management – a study of Japanese cancer-care nurses.
Filed under: Depression Treatment
Psychooncology. 2012 Sep 20;
Kaneko M, Ryu S, Nishida H, Tamasato K, Shimodaira Y,… Continue reading
Depression Treatment: Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State Has a Unique Metabolic Profile.
Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile.
Filed under: Depression Treatment
Sci Rep. 2012; 2: 667
Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK,… Continue reading